EXHIBIT 11.1 SONUS PHARMACEUTICALS, INC. COMPUTATION OF NET INCOME (LOSS) PER SHARE
Three Months Ended Six Months Ended June 30, June 30, ----------------------------------- ------------------------------------- 1996 1995 1996 1995 -------------- --------------- --------------- ---------------- Net income (loss) . . . . . . . . . . . . . . . $ 980,922 $ (1,624,111) $ (3,726,782) $ (890,983) Weighted average shares outstanding . . . . . . 8,461,220 2,050,032 8,455,550 3,330,201 ============== =============== =============== ================ Net effect of common stock equivalents calculated using the treasury stock method at the average quarterly price of $18.64 per share, and treated as outstanding for all periods presented . . . . 629,725 - - - -------------- --------------- --------------- ---------------- Shares used in computation of net income (loss) per share. . . . . . . . . . . . . . . 9,090,945 2,050,032 8,455,550 3,330,201 ============== =============== =============== ================ Net income (loss) per share . . . . . . . . . . $ 0.11 $ (0.79) $ (0.44) $ (0.27) ============== =============== =============== ================